CORD-19:ee0a7632371a08727d41e55aad7d621daeceef7d / 81021-81419 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T26579","span":{"begin":0,"end":398},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Fifty-one bone marrow samples previously characterized with NGS methods from patients with acute myeloid leukemia/myeloproliferative neoplasm were compared in a double blind fashion to the results obtained using an AML gene panel with 548 amplicons covering clinical relevant regions in 49 genes using single molecule droplet PCR (ThunderBolts Myeloid Panel, RainDance Technologies; Billerica, MA)."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T326","span":{"begin":0,"end":398},"obj":"Sentence"}],"text":"Fifty-one bone marrow samples previously characterized with NGS methods from patients with acute myeloid leukemia/myeloproliferative neoplasm were compared in a double blind fashion to the results obtained using an AML gene panel with 548 amplicons covering clinical relevant regions in 49 genes using single molecule droplet PCR (ThunderBolts Myeloid Panel, RainDance Technologies; Billerica, MA)."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T176","span":{"begin":91,"end":113},"obj":"Phenotype"},{"id":"T177","span":{"begin":133,"end":141},"obj":"Phenotype"},{"id":"T178","span":{"begin":215,"end":218},"obj":"Phenotype"}],"attributes":[{"id":"A176","pred":"hp_id","subj":"T176","obj":"http://purl.obolibrary.org/obo/HP_0004808"},{"id":"A177","pred":"hp_id","subj":"T177","obj":"http://purl.obolibrary.org/obo/HP_0002664"},{"id":"A178","pred":"hp_id","subj":"T178","obj":"http://purl.obolibrary.org/obo/HP_0004808"}],"text":"Fifty-one bone marrow samples previously characterized with NGS methods from patients with acute myeloid leukemia/myeloproliferative neoplasm were compared in a double blind fashion to the results obtained using an AML gene panel with 548 amplicons covering clinical relevant regions in 49 genes using single molecule droplet PCR (ThunderBolts Myeloid Panel, RainDance Technologies; Billerica, MA)."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T75","span":{"begin":10,"end":21},"obj":"Body_part"}],"attributes":[{"id":"A75","pred":"uberon_id","subj":"T75","obj":"http://purl.obolibrary.org/obo/UBERON_0002371"}],"text":"Fifty-one bone marrow samples previously characterized with NGS methods from patients with acute myeloid leukemia/myeloproliferative neoplasm were compared in a double blind fashion to the results obtained using an AML gene panel with 548 amplicons covering clinical relevant regions in 49 genes using single molecule droplet PCR (ThunderBolts Myeloid Panel, RainDance Technologies; Billerica, MA)."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T431","span":{"begin":91,"end":113},"obj":"Disease"},{"id":"T433","span":{"begin":97,"end":113},"obj":"Disease"},{"id":"T434","span":{"begin":105,"end":113},"obj":"Disease"},{"id":"T435","span":{"begin":114,"end":141},"obj":"Disease"},{"id":"T436","span":{"begin":133,"end":141},"obj":"Disease"},{"id":"T438","span":{"begin":215,"end":218},"obj":"Disease"},{"id":"T56484","span":{"begin":91,"end":113},"obj":"Disease"},{"id":"T432","span":{"begin":97,"end":113},"obj":"Disease"},{"id":"T32088","span":{"begin":105,"end":113},"obj":"Disease"},{"id":"T64514","span":{"begin":114,"end":141},"obj":"Disease"},{"id":"T62792","span":{"begin":133,"end":141},"obj":"Disease"},{"id":"T437","span":{"begin":215,"end":218},"obj":"Disease"}],"attributes":[{"id":"A431","pred":"mondo_id","subj":"T431","obj":"http://purl.obolibrary.org/obo/MONDO_0015667"},{"id":"A432","pred":"mondo_id","subj":"T431","obj":"http://purl.obolibrary.org/obo/MONDO_0018874"},{"id":"A433","pred":"mondo_id","subj":"T433","obj":"http://purl.obolibrary.org/obo/MONDO_0004643"},{"id":"A434","pred":"mondo_id","subj":"T434","obj":"http://purl.obolibrary.org/obo/MONDO_0005059"},{"id":"A435","pred":"mondo_id","subj":"T435","obj":"http://purl.obolibrary.org/obo/MONDO_0020076"},{"id":"A436","pred":"mondo_id","subj":"T436","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"},{"id":"A437","pred":"mondo_id","subj":"T436","obj":"http://purl.obolibrary.org/obo/MONDO_0021079"},{"id":"A438","pred":"mondo_id","subj":"T438","obj":"http://purl.obolibrary.org/obo/MONDO_0018874"},{"id":"A439","pred":"mondo_id","subj":"T438","obj":"http://purl.obolibrary.org/obo/MONDO_0015667"},{"id":"A13768","pred":"mondo_id","subj":"T56484","obj":"http://purl.obolibrary.org/obo/MONDO_0015667"},{"id":"A11558","pred":"mondo_id","subj":"T56484","obj":"http://purl.obolibrary.org/obo/MONDO_0018874"},{"id":"A71750","pred":"mondo_id","subj":"T432","obj":"http://purl.obolibrary.org/obo/MONDO_0004643"},{"id":"A21261","pred":"mondo_id","subj":"T32088","obj":"http://purl.obolibrary.org/obo/MONDO_0005059"},{"id":"A60544","pred":"mondo_id","subj":"T64514","obj":"http://purl.obolibrary.org/obo/MONDO_0020076"},{"id":"A98880","pred":"mondo_id","subj":"T62792","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"},{"id":"A57427","pred":"mondo_id","subj":"T62792","obj":"http://purl.obolibrary.org/obo/MONDO_0021079"},{"id":"A93603","pred":"mondo_id","subj":"T437","obj":"http://purl.obolibrary.org/obo/MONDO_0018874"},{"id":"A11923","pred":"mondo_id","subj":"T437","obj":"http://purl.obolibrary.org/obo/MONDO_0015667"}],"text":"Fifty-one bone marrow samples previously characterized with NGS methods from patients with acute myeloid leukemia/myeloproliferative neoplasm were compared in a double blind fashion to the results obtained using an AML gene panel with 548 amplicons covering clinical relevant regions in 49 genes using single molecule droplet PCR (ThunderBolts Myeloid Panel, RainDance Technologies; Billerica, MA)."}